
How four technical indicators called this move weeks in advance for $IBRX
Stop and reverse
Rsi
volume
price/triangle breakout

Stop and reverse
Rsi
volume
price/triangle breakout
Theres not only the biotech and science in here, but also the macro climate and how the macro wont affect IBRX
Thanks all! https://youtu.be/sIsaEpAhkeQ
Four names. Four monster moves. One question: What do I do when "THE EVENT" happens?
I’m tearing apart the charts on IBRX (ImmunityBio), SLS (SELLAS), RVMD (Revolution Medicines), and IOVA (Iovance) — support, resistance, volume, extensions, and whether the next catalyst is a continuation or a fade.
Launch codes set for uranus
They can pre-announce just like they did in april, 10 days after Q1 ended. For these reasons, I am preparing a polynomial analysis on the different announcements that can happen.
The Good? The Great? and the DEAD !
And message me on X at deepvalue69420 if im wrong. I wont be wrong.
International revenue will pull in at LEAST 5mm for q2, with some growth from the USA market above and beyond 45mm. Hope you are prepped.
SpaceX is finally going public — here's everything you need to know about its historic IPO trading day and what investors should realistically expect in the short term, medium term, and long term.
GameStop (GME) just dropped its Q1 earnings — and they’re the highest in company history! 🚀
In this video, we break down the full earnings report and revisit the big question everyone’s asking:
What are the real Pros & Cons of GameStop’s growing equity stake in eBay?
Bitcoin Totally decoupled from high flying SP500: Is Crypto Finally Done? In this video you will find high logic and reasoning, as well as some thesis I have on which alt coins make sense to me.
In this 10+ minute breakdown, go through the current technical setup for ImmunityBio (IBRX) — key support/resistance levels, bollinger bands, and psyche of the market.
SELLAS Life Sciences (SLS) is a late-stage biotech with massive buyout potential. Their lead asset GPS (Galinpepimut-S) just hit 78/80 events in the pivotal Phase 3 REGAL trial in AML — topline data expected any day.
Why Big Pharma (BMS, Pfizer, AbbVie) could buy them out!
High-risk, high-reward AML play. DYOR.$SLS #Biotech #Buyout
I need a retweet on this, thanks
https://x.com/Deepvalue69420/status/2058868105296892394?s=20
Statistically significant data: Anktiva vs Keytruda and Anktiva+Chemo vs Keytruda + Chemo
In this video I break down:
• The explosive new tweet from u/MiNK_iNKT showing real pathogen suppression and lung tissue repair using agenT-797 + ANKTIVA
• Simple breakdown of what INKT actually is and what they do
• Where INKT sits vs IBRX on the Biotech Lifecycle chart
• Why this micro-cap could deliver massive returns on the back of its IBRX relationship and upcoming performance